Baolingbao Biology Co.,Ltd. (SHE:002286)

China flag China · Delayed Price · Currency is CNY
10.26
-0.03 (-0.29%)
Apr 22, 2026, 9:45 AM CST
Market Cap3.92B +32.9%
Revenue (ttm)2.69B +12.6%
Net Income144.09M +32.1%
EPS0.39 +26.5%
Shares Out380.57M
PE Ratio26.35
Forward PEn/a
Dividend0.12 (1.17%)
Ex-Dividend DateJul 3, 2025
Volume1,092,500
Average Volume7,290,287
Open10.34
Previous Close10.29
Day's Range10.16 - 10.34
52-Week Range7.48 - 13.40
Beta0.59
RSI55.79
Earnings DateApr 25, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,395
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002286
Full Company Profile

Financial Performance

In 2024, Baolingbao Biology's revenue was 2.40 billion, a decrease of -4.84% compared to the previous year's 2.52 billion. Earnings were 111.16 million, an increase of 105.97%.

Financial Statements